New ANDA Cases - Summer 2019

Robins Kaplan LLP
Contact

Robins Kaplan LLP

Summer 2019

Case Name Date Filed Judge Drug Patent No(s).
Bausch Health Ireland Ltd. v. Lupin Ltd., 19-9178 (D.N.J.) Apr. 1, 2019 Hon. Renee Marie Bumb Plenvu® (polyethylene glycol 3350 / sodium ascorbate / sodium sulfate / ascorbic acid / sodium chloride / potassium chloride oral solution) 8,999,313
9,626,969
9,592,252
9,707,297
10,016,504
Lipocine Inc. v. Clarus Therapeutics, Inc., 19-0622 (D. Del.) Apr. 2, 2019 Hon. Leonard P. Stark Jatenzo® (testosterone undecanoate capsules)
Tlando™ (testerone undecanoate capusules)
9,034,858
9,205,057
9,480,690
9,757,390
6,569,463
6,923,988
Bausch Health Ireland Ltd. v. Lupin Ltd., 19-0626 (D. Del.) Apr. 3, 2019 Hon. Colm F. Connolly Plenvu® (polyethylene glycol 3350 / sodium ascorbate / sodium sulfate / ascorbic acid / sodium chloride / potassium chloride oral solution) 8,999,313
9,326,969
9,592,252
9,707,297
10,016,504
Ferring Pharms. Inc. v. Hetero USA Inc., 19-0634 (D. Del.) Apr. 4, 2019 Hon. Richard G. Andrews Prepopik® (citric acid / magnesium oxide / sodium picosulfate oral solution) 8,450,338
8,481,083
Sun Pharm. Indus. Ltd. v. Pfizer, Inc., 19-9330 (D.N.J.) Apr. 5, 2019 Hon. Kevin McNulty Lyrica® CR (pregabalin extended-release tablets) 9,393,205
Sun Pharm. Indus. Ltd. v. Pfizer, Inc., 19-9335 (D.N.J.) Apr. 5, 2019 Hon. Kevin McNulty Lyrica® CR (pregabalin extended-release tablets) 8,945,620
9,144,559
10,022,447
Almirall, LLC v. Amneal Pharms. LLC, 19-0658 (D. Del.) Apr. 9, 2019 Hon. Leonard P. Stark Aczone® (dapsone gel) 9,517,219
Silvergate Pharms., Inc. v. Amneal Pharms. LLC, 19-0678 (D. Del.) Apr. 11, 2019 Hon. Leonard P. Stark Epaned® (enalapril maleate oral solution) 9,669,008
9,80,8442
10,039,745
10,154,987
Vanda Pharms. Inc. v. Apotex Inc., 19-0685 (D. Del.) Apr. 12, 2019 Hon. Colm F. Connolly Hetlioz® (tasimelteon capsules) 10,149,829
Celgene Corp. v. Synthon Pharms. Inc., 19-9737 (D.N.J.) Apr. 12, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Allergan Sales, LLC v. Micro Labs Ltd., 19-9759 (D.N.J.) Apr. 12, 2019 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules) 8,481,598
8,864937
RE43879
Celgene Corp. v. Sun Pharma Global FZE, 19-10099 (D.N.J.) Apr. 16, 2019 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,977,357
8,193,219
8,431,598
Par Pharm., Inc. v. Amneal Pharms. Co. GmbH, 19-0712 (D. Del.) Apr. 18, 2019 Hon. Colm F. Connolly Vasostrict® (vasopressin for injection) 9,744,209
9,750,985
Inspirion Delivery Sciences, LLC v. Teva Pharms. USA, Inc., 19-10464 (D.N.J.) Apr. 19, 2019 Hon. Madeline Cox Arleo MorphaBond® (morphine sulfate extended-release tablets) 7,955,619
Bausch Health Ireland Ltd. v. Zydus Pharms. (USA), Inc., 19-10645 (D.N.J.) Apr. 22, 2019 Hon. Renee Marie Bumb Glumetza® (metformin HCl extended-release tablets) 6,488,962
6,723,340
7,780,987
8,323,692
Cipla Ltd. v. AstraZeneca AB, 19-0733 (D. Del.) Apr. 24, 2019 Hon. Maryellen Noreika Nexium® (esomeprazole magnesium delayed-release oral suspension) 6,428,810
Salix Pharms., Ltd. v. Sun Pharms. Indus., Ltd., 19-0734 (D. Del.) Apr. 24, 2019 Hon. Richard G. Andrews Xifaxan® (rifaximin tablets) 7,045,620
7,612,199
7,902,206
7,906,542
8,158,644
8,158,781
8,835,452
8,853,231
7,915,275
8,193,196
8,518,949
8,741,904
9,271,968
7,928,115
Osi Pharms., LLC v. Zydus Pharms. (USA) Inc., 19-0741 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Tarceva® (erlotinib HCl tablets) 6,900,221
Pfizer Inc. v. Aizant Drug Research Solutions Pvt. Ltd., 19-0743 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Alembic Pharms., Inc., 19-0745 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
Pfizer Inc. v. Apotex Inc., 19-0747 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Aurobindo Pharma, Ltd., 19-0748 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Cipla USA Inc., 19-0749 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Dr. Reddy’s Labs., Inc., 19-0750 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Hetero USA, Inc., 19-0751 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Mylan Pharms. Inc., 19-0752 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Natco Pharma, Inc., 19-0753 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Qilu Pharma, Inc., 19-0754 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Sun Pharm. Indus., Ltd., 19-0758 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
Pfizer Inc. v. Teva Pharms. USA, Inc., 19-0759 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 19-0760 (D. Del.) Apr. 25, 2019 Hon. Colm F. Connolly Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Teijin Ltd. v. Alkem Labs. Ltd., 19-0768 (D. Del.) Apr. 26, 2019 Hon. Richard G. Andrews Uloric® (febuxostat tablets) 7,361,676
8,372,872
9,107,912
Adamis Pharms. Corp. v. Belcher Pharms., LLC, IPR2019-01021 (PTAB) Apr. 26, 2019 N/A Epinephrine for injection 9,283,197
Pfizer Inc. v. Aizant Drug Research Solutions Pvt. Ltd., 19-11737 (D.N.J.) Apr. 29, 2019 Hon. Renee Marie Bumb Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Dr. Reddy’s Labs., Inc., 19-11742 (D.N.J.) Apr. 29, 2019 Hon. Renee Marie Bumb Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Sun Pharm. Indus., Ltd., 19-11746 (D.N.J.) Apr. 29, 2019 Hon. Renee Marie Bumb Ibrance® (palbociclib capsules) 6,936,612
7,208,489
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 19-11748 (D.N.J.) Apr. 29, 2019 Hon. Renee Marie Bumb Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Mylan Pharms. Inc., 19-0097 (N.D.W.V.) Apr. 29, 2019 Hon. Irene M. Keeley Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Pfizer Inc. v. Qilu Pharma, Inc., 19-1846 (E.D. Pa.) Apr. 29, 2019 Hon. Gene E.K. Pratter Ibrance® (palbociclib capsules) 6,936,612
7,208,489
7,456,168
Arena Pharms., Inc. v. Aurobindo Pharma Ltd., 19-0811 (D. Del.) May 1, 2019 Hon. Richard G. Andrews Belviq® (lorcaserin HCl tablets) 6,953,787
7,514,422
7,977,329
8,207,158
8,273,734
9,770,455
Bausch Health Ireland Ltd. v. Glenmark Pharms. Ltd., 19-12045 (D.N.J.) May 1, 2019 Hon. Renee Marie Bumb Glumetza® (metformin HCl extended-release tablets) 6,488,962
6,723,340
7,780,987
8,323,692
Merck Sharp & Dohme Corp. v. Mylan Pharms. Inc., 19-0101 (N.D.W.V.) May 2, 2019 Hon. Irene M. Keeley Januvia® (sitagliptin phosphate tablets)
Janumet® (metformin HCI / stagliptin phosphate tablets)
7,326,708
8,414,921
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00977 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,603,044
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00978 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,603,044
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00979 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,679,069
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00980 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,992,486
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00981 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,992,486
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00982 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
8,992,486
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00987 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
9,604,008
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-01022 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
9,526,844
Pfizer Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-01023 (PTAB) May 2, 2019 N/A Lantus® Solostar (insulin glargine recombinant for injection)
Apidra® Solostar (insulin glulisine recombinant for injection)
Toujeo® Max Solostar (insulin glargine recombinant subcutaneous solution)
Toujeo® Solostar (insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcanteous solution)
Admelog® Solostar (insulin lispro for injecction)
9,526,844
Teva Pharms. USA, Inc. v. Corcept Therapeutics, Inc., PGR2019-00048 (PTAB) May 7, 2019 N/A Korlym® (mifepristone tablets) 10,195,214
Merck Sharp & Dohme Corp. v. Torrent Pharms. Ltd., 19-0872 (D. Del.) May 9, 2019 Hon. Richard G. Andrews Janumet® (metformin HCl / sitagliptin phosphate tablets) 7,326,708
Collegium Pharm., Inc. v. Teva Pharms. USA Inc., 19-0876 (D. Del.) May 9, 2019 Hon. Leonard P. Stark Xtampza® ER (oxycodone extended-release capsules) 10,188,644
Bausch Health Ireland Ltd. v. Teva Pharms. USA, Inc., 19-12404 (D.N.J.) May 9, 2019 Hon. Renee Marie Bumb Plenvu® (polyethylene glycol 3350 / sodium ascorbate / sodium sulfate / ascorbic acid / sodium chloride / potassium chloride oral solution) 8,999,313
9,326,969
9,292,252
9,707,297
10,016,504
Bayer Intellectual Property Gmbh v. Macleods Pharms. Ltd., 19-0880 (D. Del.) May 10, 2019 Hon. Timothy B. Dyk Xarelto® (rivaroxaban tablets) 9,539,218
Hikma Pharms. USA Inc. v. Micro Labs Ltd., 19-0883 (D. Del.) May 10, 2019 Hon. Colm F. Connolly Mitigare® (colchicine capsules) 8,927,607
9,399,036
9,555,029
9,675,613
9,789,108
Keryx Biopharms., Inc. v. Lupin Ltd., 19-0884 (D. Del.) May 10, 2019 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 5,753,706
7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,387,191
9,757,416
Keryx Biopharms., Inc. v. Watson Labs., Inc., 19-0885 (D. Del.) May 10, 2019 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 7,767,851
8.093.423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,757,416
Fresenius Medical Care Holdings, Inc. v. Suven Life Sciences Ltd., 19-12479 (D.N.J.) May 13, 2019 Hon. Freda L. Wolfson PhosLo® GelCaps (calcium acetate tablets) 6,576,665
6,875,445
AstraZeneca Pharms. LP v. Aurobindo Pharma Ltd., 19-12567 (D.N.J.) May 15, 2019 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 8,536,206
8,604,064
8,618,142
Keryx Biopharms., Inc. v. Watson Labs., Inc., 19-0837 (D. Nev.) May 15, 2019 Hon. Richard F. Boulware, II Auryxia® (ferric citrate tablets) 7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,757,416
Ferring Pharms. Inc. v. Lupin Inc., 19-0913 (D. Del.) May 16, 2019 Hon. Richard G. Andrews Clenpiq® (sodium picosulfate / magnesium oxide / anhydrous citric acid oral solution) 9,827,231
9,669,110
Kaleo, Inc. v. Adamis Pharms. Corp., 19-0917 (D. Del.) May 16, 2019 Hon. Richard G. Andrews Evzio® (naloxone HCl for injection) 9,022,022
10,143,792
10,238,806
Keryx Biopharms., Inc. v. Par Pharm., Inc., 19-0955 (D. Del.) May 23, 2019 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 8,093,423
9,387,191
CyDex Pharms., Inc. v. Alembic Global Holding SA, 19-0956 (D. Del.) May 23, 2019 Hon. Leonard P. Stark Evomela® (melphalan HCl for injection) 9,200,088
9,493,582
Valeant Pharms. North America LLC v. KVK-Tech, Inc., 19-12845 (D.N.J.) May 23, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Cubist Pharms. LLC v. Cipla USA, Inc., 19-12920 (D.N.J.) May 24, 2019 Hon. Brian R. Martinotti Cubicin RF® (daptomycin for injection) 9,138,456
Keryx Biopharms., Inc. v. Par Pharm., Inc., 19-4876 (S.D.N.Y.) May 24, 2019 Hon. Edgardo Ramos Auryxia® (ferric citrate tablets) 8,093,423
9,387,191
Actelion Pharms. Ltd. v. Natco Pharma Ltd., 19-12984 (D.N.J.) May 28, 2019 Hon. Brian R. Martinotti Tracleer® (bosentan tablets) 8,309,126
Senju Pharm. Co., Ltd. v. Aurobindo Pharma USA Inc., 19-13348 (D.N.J.) June 3, 2019 Hon. Brian R. Martinotti Prolensa® (bromfenac ophthalmic solution) 8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
9,144,609
9,517,220
9,561,277
10,085,958
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 19-1042 (D. Del.) June 5, 2019 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
8,778,962
8,436,010
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 19-0120 (ND.W.V.) June 6, 2019 Hon. Irene M. Keeley Afinitor® (everolimus tablets) 5,665,772
8,778,962
8,436,010
Silvergate Pharms., Inc. v. Bionpharma Inc., 19-1067 (D. Del.) June 7, 2019 Hon. Leonard P. Stark Epaned® (enalapril maleate oral solution) 10,154,987
Mylan Pharms. Inc. v. Almirall, LLC, IPR2019-01095 (PTAB) June 7, 2019 N/A Aczone® (dapsone gel) 9,517,219
Bausch Health Cos. Inc. v. Actavis Labs. FL, Inc., 19-13722 (D.N.J.) June 13, 2019 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide tablets) 10,307,417
Novartis Pharms. Corp. v. Mylan Pharms., Inc., 19-1118 (D. Del.) June 17, 2019 Hon. Leonard P. Stark Gilenya® (fingolimod capsules) 9,187,405
Vifor (Int’l) AG v. Mylan Labs. Ltd., 19-13955 (D.N.J.) June 18, 2019 Hon. Freda L. Wolfson Injectafer® (ferric carboxymaltose for injection) 7,612,109
7,754,702
8,895,612
9,376,505
Celgene Corp. v. Apotex Inc., 19-13994 (D.N.J.) June 19, 2019 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,977,357
8,193,219
8,431,598
Astellas US LLC v. Dr. Reddy’s Labs., Ltd., 19-1160 (D. Del.) June 21, 2019 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8,106,183
RE47,301
8,524,883
Vifor (Int’l) AG v. Mylan Labs. Ltd., 19-0126 (N.D.W.V.) June 20, 2019 Hon. Thomas S. Kleeh Injectafer® (ferric carboxymaltose for injection) 7,612,109
7,754,702
8,895,612
9,376,505
Astellas US LLC v. Accord Healthcare, Inc., 19-1199 (D. Del.) June 25, 2019 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8,106,183
RE47,301
8,524,883
Novartis Pharms. Corp. v. Mylan Pharms., Inc., 19-0128 (N.D.W.V.) June 25, 2019 Hon. Thomas S. Kleeh Gilenya® (fingolimod capsules) 9,187,405
Pfizer Inc. v. Glenmark Pharms. Ltd., 19-1209 (D. Del.) June 26, 2019 Hon. Richard G. Andrews Inlyta® (axitinib tablets) 8,791,140
Eisai Co. v. Alkem Labs. Ltd., 19-1213 (D. Del.) June 26, 2019 Hon. Leonard P. Stark Banzel® (rufinamide oral suspension) 6,740,669
Eisai Co. v. Glenmark Pharms. Ltd., 19-1214 (D. Del.) June 26, 2019 Hon. Leonard P. Stark Banzel® (rufinamide oral suspension) 6,740,669
Piramal Healthcare UK Ltd. v. Sumitomo Dainippon Pharma Co., Ltd., 19-14307 (D.N.J.) June 26, 2019 Hon. Stanley R. Chesler Latuda® (lurasidone HCl tablets) 8,729,085
Eisai Co. v. Alkem Labs. Ltd., 19-14394 (D.N.J.) June 27, 2019 Hon. John Michael Vazquez Banzel® (rufinamide oral suspension) 6,740,669
Bayer Intellectual Property Gmbh v. Accord Healthcare, Inc., 19-1238 (D. Del.) June 28, 2019 Hon. Timothy Belcher Dyk Xarelto® (rivaroxaban tablets) 9,539,218
Bausch Health Ireland Ltd. v. Apotex Inc., 19-14474 (D.N.J.) June 28, 2019 Hon. Renee Marie Bumb Glumetza® (metformin HCl extended-release tablets) 7,780,987
8,323,692
Bausch Health Ireland Ltd. v. Emcure Pharms. Ltd., 19-14480 (D.N.J.) June 28, 2019 Hon. Renee Marie Bumb Glumetza® (metformin HCl extended-release tablets) 6,723,340
7,780,987
8,323,692
Bausch Health Ireland Ltd. v. Granules India Ltd., 19-14489 (D.N.J.) June 28, 2019 Hon. Renee Marie Bumb Glumetza® (metformin HCl extended-release tablets) 6,723,340
7,780,987
8,323,692
Bausch Health Ireland Ltd. v. Glenmark Pharms. Ltd, 19-14502 (D.N.J.) June 28, 2019 Hon. Freda L. Wolfson Bryhali® (halobetasol propionate lotion) 8,809,307

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins Kaplan LLP | Attorney Advertising

Written by:

Robins Kaplan LLP
Contact
more
less

Robins Kaplan LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide